1-Year Real-World Outcomes of TAVR With the Fifth-Generation Balloon-Expandable Valve in the United States

Keyphrases

• United States 100%
• Transcatheter Aortic Valve Replacement 100%
• SAPIEN 3 100%
• Balloon-expandable Valve 100%
• Real-world Outcomes 100%
• Fifth Generation 100%
• RESILIA 61%
• Paravalvular Leak 16%
• Clinical Outcomes 11%
• Propensity Matching 11%
• Reintervention 11%
• All-cause Mortality 5%
• At Discharge 5%
• Society of Thoracic Surgeons 5%
• Follow-up Time 5%
• Long Follow-up 5%
• 1-year Mortality 5%
• Low-risk Patients 5%
• 1-year Outcome 5%
• National Registry 5%
• Life-threatening Bleeding 5%
• Mean Gradient 5%
• Echocardiographic Outcomes 5%
• Low Discharge 5%
• Effective Orifice Area 5%
• Transcatheter Valve Therapy Registry 5%
• Low Gradient 5%
• Sapien Valve 5%

Medicine and Dentistry

• Percutaneous Aortic Valve Replacement 100%
• Paravalvular Leak 75%
• All Cause Mortality 25%
• Bleeding 25%
• Surgeon 25%